Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →
| Conto economico | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Entrate totali | $2.6B | $2.3B | $1.5B | $872M | $527M | $272M | $149M | $83M | $27M |
| Utile lordo | $1.7B | $1.7B | $1.2B | $715M | $409M | $204M | $109M | $45M | $8M |
| Margine lordo% | 64.7% | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% | 73.6% | 54.0% | 29.2% |
| Risultato Operativo (EBIT) | ($93M) | $106M | $62M | ($29M) | ($69M) | ($115M) | ($15M) | ($74M) | ($76M) |
| Margine operativo % | -3.6% | 4.5% | 4.2% | -3.4% | -13.0% | -42.3% | -10.2% | -90.1% | -284.0% |
| Reddito netto | ($142M) | $128M | $126M | ($24M) | ($66M) | ($108M) | ($18M) | ($72M) | ($75M) |
| Margine netto% | -5.5% | 5.5% | 8.5% | -2.7% | -12.5% | -39.6% | -12.2% | -87.3% | -282.0% |
| EBITDA | ($76M) | $178M | $89M | ($12M) | ($58M) | ($107M) | ($14M) | ($71M) | — |
| Utile per azione (EPS) | $-0.63 | $0.50 | $0.53 | $-0.11 | $-0.32 | $-0.58 | $-0.51 | $-2.07 | $-1.12 |
| Azioni in circolazione (M) | 232M | 258M | 237M | 209M | 205M | 187M | 35M | 35M | 67M |
Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.
Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di HIMS. /companies/us/HIMS
Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.
About TickerBase · Data methodology & sources · Privacy · Terms